{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T10:11:11Z","timestamp":1790331071297,"version":"4.1.0"},"reference-count":149,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Reports"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.toxrep.2026.102292","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T06:37:28Z","timestamp":1781159848000},"page":"102292","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Synthetic biology of oncolytic bacteria: Comparative microbial chassis and precise killing strategies"],"prefix":"10.1016","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6418-2574","authenticated-orcid":false,"given":"Mustafa Attiyah","family":"Hadid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nawfal Haitham Al","family":"Shaikhli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar Khalid","family":"Suhail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samar T.","family":"Hameed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhtada Ali","family":"Challoob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.toxrep.2026.102292_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA: Cancer J. Clin."},{"issue":"2","key":"10.1016\/j.toxrep.2026.102292_bib2","first-page":"328","article-title":"Application of MXenes in Tumor Therapy","volume":"51","author":"Liu","year":"2024","journal-title":"Progress. Biochem. Biophys."},{"key":"10.1016\/j.toxrep.2026.102292_bib3","doi-asserted-by":"crossref","first-page":"110409","DOI":"10.1016\/j.biopha.2020.110409","article-title":"Probiotics for cancer alternative prevention and treatment","volume":"129","author":"Bedada","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.toxrep.2026.102292_bib4","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3390\/cancers11010038","article-title":"Gut microbiota and cancer: from pathogenesis to therapy","volume":"11","author":"Vivarelli","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.toxrep.2026.102292_bib5","doi-asserted-by":"crossref","unstructured":"Dang L.H., Bettegowda C., Huso D.L., Kinzler K.W., Vogelstein B. Combination bacteriolytic therapy for the treatment of experimental tumors. Proceedings of the National Academy of Sciences. 2001 Dec 18;98(26):15155-60.","DOI":"10.1073\/pnas.251543698"},{"key":"10.1016\/j.toxrep.2026.102292_bib6","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jconrel.2014.12.014","article-title":"Trg-deficient Salmonella colonize quiescent tumor regions by exclusively penetrating or proliferating","volume":"199","author":"Zhang","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.toxrep.2026.102292_bib7","article-title":"Bacterial oncolytic therapy as a novel approach for cancer treatment in humans","volume":"43","author":"Ali","year":"2025","journal-title":"Cancer Treat. Res. Commun."},{"key":"10.1016\/j.toxrep.2026.102292_bib8","first-page":"1497","article-title":"Bacterial-based cancer therapy (Bbct): Recent advances, current challenges, and future prospects for cancer immunotherapy","volume":"9","author":"Gupta","year":"2021"},{"key":"10.1016\/j.toxrep.2026.102292_bib9","first-page":"154","article-title":"The toxins of William B. Coley and the treatment of bone and soft-tissue sarcomas","volume":"26","author":"McCarthy","year":"2006","journal-title":"Lowa Orthop. J."},{"issue":"33","key":"10.1016\/j.toxrep.2026.102292_bib10","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba3546","article-title":"Bacteria-triggered tumor-specific thrombosis to enable potent photothermal immunotherapy of cancer","volume":"6","author":"Yi","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.toxrep.2026.102292_bib11","article-title":"Bacteria-Based Cancer Immunotherapy","volume":"8","author":"Huang","year":"2021"},{"issue":"7","key":"10.1016\/j.toxrep.2026.102292_bib12","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/j.cell.2025.02.002","article-title":"Bacterial immunotherapy leveraging IL-10R hysteresis for both phagocytosis evasion and tumor immunity revitalization","volume":"188","author":"Chang","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.toxrep.2026.102292_bib13","article-title":"Bacteria-based immunotherapy for cancer: a systematic review of preclinical studies","volume":"14","author":"Zhou","year":"2023"},{"key":"10.1016\/j.toxrep.2026.102292_bib14","first-page":"95","article-title":"Bacteriocins-a viable alternative to antibiotics?","volume":"11","author":"Cotter","year":"2013"},{"key":"10.1016\/j.toxrep.2026.102292_bib15","first-page":"858","article-title":"Engineering bacteria as interactive cancer therapies","volume":"378","author":"Gurbatri","year":"2022"},{"key":"10.1016\/j.toxrep.2026.102292_bib16","first-page":"730","article-title":"Theranostic cells: emerging clinical applications of synthetic biology","volume":"22","author":"McNerney","year":"2021"},{"key":"10.1016\/j.toxrep.2026.102292_bib17","first-page":"941","article-title":"Engineering living therapeutics with synthetic biology","volume":"20","author":"Cubillos-Ruiz","year":"2021"},{"key":"10.1016\/j.toxrep.2026.102292_bib18","first-page":"214","article-title":"Engineering bacteria for diagnostic and therapeutic applications","volume":"16","author":"Riglar","year":"2018"},{"issue":"1","key":"10.1016\/j.toxrep.2026.102292_bib19","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2228045","article-title":"Strain-level screening of human gut microbes identifies Blautia producta as a new anti-hyperlipidemic probiotic","volume":"15","author":"Xu","year":"2023","journal-title":"Gut Microbes"},{"issue":"4","key":"10.1016\/j.toxrep.2026.102292_bib20","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.chom.2019.02.005","article-title":"Adaptive Strategies of the Candidate Probiotic E. coli Nissle in the Mammalian Gut","volume":"25","author":"Crook","year":"2019","journal-title":"Cell. Host Microbe"},{"key":"10.1016\/j.toxrep.2026.102292_bib21","doi-asserted-by":"crossref","DOI":"10.1186\/1475-2859-5-23","article-title":"Live bacterial vaccines - A review and identification of potential hazards. In","volume":"5","author":"Detmer","year":"2006","journal-title":"Microb. Cell. Factor."},{"issue":"4","key":"10.1016\/j.toxrep.2026.102292_bib22","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/procel\/pwaf085","article-title":"Engineering oncolytic bacteria as precision cancer therapeutics: design principles, therapeutic strategies, and translational perspectives","volume":"17","author":"Niu","year":"2025","journal-title":"Protein & Cell."},{"key":"10.1016\/j.toxrep.2026.102292_bib23","first-page":"9726","article-title":"Bacterial Therapy of Cancer: A Way to the Dustbin of History or to the Medicine of the Future?","volume":"24","author":"Ikryannikova","year":"2023"},{"issue":"1","key":"10.1016\/j.toxrep.2026.102292_bib24","doi-asserted-by":"crossref","DOI":"10.29173\/eureka28822","article-title":"How Fundamental Research on T cell Biology Started a Revolution in Cancer Therapy Development","volume":"9","author":"Mula","year":"2024","journal-title":"Eureka"},{"issue":"5","key":"10.1016\/j.toxrep.2026.102292_bib25","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3109\/02841869009090048","article-title":"The spontaneous regression of cancer: a review of cases from 1900 to 1987","volume":"29","author":"Challis","year":"1990","journal-title":"Acta Oncologica"},{"issue":"12","key":"10.1016\/j.toxrep.2026.102292_bib26","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.7150\/thno.11432","article-title":"Salmonella typhimurium suppresses tumor growth via the pro-inflammatory cytokine interleukin-1\u03b2","volume":"5","author":"Kim","year":"2015","journal-title":"Theranostics"},{"key":"10.1016\/j.toxrep.2026.102292_bib27","doi-asserted-by":"crossref","DOI":"10.1177\/11795549241234637","article-title":"Helicobacter pylori and Gastrointestinal Cancers: Recent Advances and Controversies","volume":"18","author":"Zhang","year":"2024","journal-title":"Clin. Med. Insights Oncol."},{"key":"10.1016\/j.toxrep.2026.102292_bib28","first-page":"1","article-title":"Bacteria-cancer interactions: bacteria-based cancer therapy","volume":"51","author":"Duong","year":"2019"},{"key":"10.1016\/j.toxrep.2026.102292_bib29","first-page":"866","article-title":"Transforming bacterial pathogens into wonder tools in cancer immunotherapy","volume":"33","author":"Senevirathne","year":"2025"},{"issue":"1","key":"10.1016\/j.toxrep.2026.102292_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101985","article-title":"Engineering approaches for studying immune-tumor cell interactions and immunotherapy","volume":"24","author":"Shelton","year":"2021","journal-title":"Iscience"},{"key":"10.1016\/j.toxrep.2026.102292_bib31","article-title":"Metabolic reprogramming in cancer: Mechanisms and therapeutics","volume":"4","author":"Nong","year":"2023"},{"issue":"1","key":"10.1016\/j.toxrep.2026.102292_bib32","article-title":"Inflammation and tumor progression: signaling pathways and targeted intervention","volume":"6","author":"Zhao","year":"2021","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"2","key":"10.1016\/j.toxrep.2026.102292_bib33","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2267189","article-title":"Quorum sensing modulates bacterial virulence and colonization dynamics of the gastrointestinal pathogen Citrobacter rodentium","volume":"15","author":"Pe\u00f1a-D\u00edaz","year":"2023","journal-title":"Gut Microbes"},{"issue":"11","key":"10.1016\/j.toxrep.2026.102292_bib34","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1016\/j.apsb.2020.04.004","article-title":"The role of tumor-associated macrophages (TAMs) in tumor progression and relevant advance in targeted therapy","volume":"10","author":"Yang","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.toxrep.2026.102292_bib35","article-title":"Obligate and facultative anaerobic bacteria in targeted cancer therapy: Current strategies and clinical applications","volume":"261","author":"Dr\u00f3\u017cd\u017c","year":"2020"},{"issue":"8","key":"10.1016\/j.toxrep.2026.102292_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006692","article-title":"Tumor invasion of Salmonella enterica serovar Typhimurium is accompanied by strong hemorrhage promoted by TNF-\u03b1","volume":"4","author":"Leschner","year":"2009","journal-title":"PLoS. ONE"},{"issue":"11","key":"10.1016\/j.toxrep.2026.102292_bib37","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1038\/bjc.2013.206","article-title":"Myeloid-derived suppressor cells have a central role in attenuated Listeria monocytogenes-based immunotherapy against metastatic breast cancer in young and old mice","volume":"108","author":"Chandra","year":"2013","journal-title":"Br. J. Cancer"},{"issue":"21","key":"10.1016\/j.toxrep.2026.102292_bib38","doi-asserted-by":"crossref","first-page":"8668","DOI":"10.1073\/pnas.1211287110","article-title":"Nontoxic radioactive Listeriaat is a highly effective therapy against metastatic pancreatic cancer","volume":"110","author":"Quispe-Tintaya","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"8","key":"10.1016\/j.toxrep.2026.102292_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/jpm11080771","article-title":"The enhanced permeability and retention (Epr) effect: The significance of the concept and methods to enhance its application","volume":"11","author":"Wu","year":"2021","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.toxrep.2026.102292_bib40","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jconrel.2023.07.039","article-title":"Targeting endothelial permeability in the EPR effect","volume":"361","author":"Lahooti","year":"2023","journal-title":"J. Control. Release"},{"issue":"6","key":"10.1016\/j.toxrep.2026.102292_bib41","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.3390\/app15063189","article-title":"Enhancement of EPR effect for passive tumor targeting: current status and future perspectives","volume":"15","author":"Vagena","year":"2025","journal-title":"Appl. Sci."},{"key":"10.1016\/j.toxrep.2026.102292_bib42","doi-asserted-by":"crossref","unstructured":"Yhee, J.Y., Son, S., Son, S., Joo, M.K. and Kwon, I.C., 2013. The EPR effect in cancer therapy. In Cancer targeted drug delivery: an elusive dream (pp. 621-632). New York, NY: Springer New York.","DOI":"10.1007\/978-1-4614-7876-8_23"},{"issue":"6","key":"10.1016\/j.toxrep.2026.102292_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24065069","article-title":"Modulation of the Tumor Microenvironment by Microbiota-Derived Short-Chain Fatty Acids: Impact in Colorectal Cancer Therapy","volume":"24","author":"Gomes","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.toxrep.2026.102292_bib44","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13046-020-01820-7","article-title":"Targeting hypoxia in the tumor microenvironment: a potential strategy to improve cancer immunotherapy","volume":"40","author":"Wang","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"12","key":"10.1016\/j.toxrep.2026.102292_bib45","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1038\/nbt1256","article-title":"The genome and transcriptomes of the anti-tumor agent Clostridium novyi-NT","volume":"24","author":"Bettegowda","year":"2006","journal-title":"Nat. Biotechnol."},{"issue":"2","key":"10.1016\/j.toxrep.2026.102292_bib46","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.gendis.2016.01.003","article-title":"Clostridium novyi-NT in cancer therapy","volume":"3","author":"Staedtke","year":"2016","journal-title":"Genes. Dis."},{"issue":"3","key":"10.1016\/j.toxrep.2026.102292_bib47","doi-asserted-by":"crossref","first-page":"387","DOI":"10.48022\/mbl.2204.04005","article-title":"Anticancer and Cytotoxic Effect of Verotoxin 1 on Colon Cancer Cell Line","volume":"50","author":"Hadid","year":"2022","journal-title":"Microbiol. Biotechnol. Lett."},{"issue":"42","key":"10.1016\/j.toxrep.2026.102292_bib48","doi-asserted-by":"crossref","first-page":"15172","DOI":"10.1073\/pnas.0406242101","article-title":"Bacteriolytic therapy can generate a potent immune response against experimental tumors","volume":"101","author":"Agrawal","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.toxrep.2026.102292_bib49","doi-asserted-by":"crossref","first-page":"903","DOI":"10.3892\/ijo.2013.1790","article-title":"Clostridium butyricum MIYAIRI 588 shows antitumor effects by enhancing the release of TRAIL from neutrophils through MMP-8","volume":"42","author":"Shinnoh","year":"2013","journal-title":"Int. J. Oncol."},{"issue":"10","key":"10.1016\/j.toxrep.2026.102292_bib50","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.7150\/thno.16135","article-title":"RGD peptide cell-surface display enhances the targeting and therapeutic efficacy of attenuated Salmonella-mediated cancer therapy","volume":"6","author":"Park","year":"2016","journal-title":"Theranostics"},{"issue":"9","key":"10.1016\/j.toxrep.2026.102292_bib51","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.2174\/138161210790963788","article-title":"Peptidic tumor targeting agents: the road from phage display peptide selections to clinical applications","volume":"16","author":"Brown","year":"2010","journal-title":"Curr. Pharm. Des."},{"issue":"7","key":"10.1016\/j.toxrep.2026.102292_bib52","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1002\/bit.23095","article-title":"Engineering of Escherichia coli for targeted delivery of transgenes to HER2\/neu\u2010positive tumor cells","volume":"108","author":"Chang","year":"2011","journal-title":"Biotechnol. Bioeng."},{"issue":"5","key":"10.1016\/j.toxrep.2026.102292_bib53","first-page":"705","article-title":"Salmonella engineered to express CD20-targeting antibodies and a drug-converting enzyme can eradicate human lymphomas","volume":"122","author":"Massa","year":"2013","journal-title":"Blood, The Journal of the American Society of Hematology"},{"issue":"2","key":"10.1016\/j.toxrep.2026.102292_bib54","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1382791","article-title":"Engineered Salmonella enterica serovar Typhimurium overcomes limitations of anti-bacterial immunity in bacteria-mediated tumor therapy","volume":"7","author":"Felgner","year":"2018","journal-title":"OncoImmunology"},{"key":"10.1016\/j.toxrep.2026.102292_bib55","first-page":"5","article-title":"Synthetic Biology and Engineered Live Biotherapeutics: Toward Increasing System Complexity","volume":"7","author":"Ozdemir","year":"2018"},{"key":"10.1016\/j.toxrep.2026.102292_bib56","first-page":"1914","article-title":"Outer membrane vesicles: Versatile nanocarriers for therapeutic delivery and immune modulation","volume":"16","author":"Yang","year":"2026"},{"key":"10.1016\/j.toxrep.2026.102292_bib57","first-page":"27","article-title":"Genetically engineered bifidobacterium as a drug delivery system for systemic therapy of metastatic breast cancer patients","volume":"13","author":"Fujimori","year":"2006"},{"issue":"8","key":"10.1016\/j.toxrep.2026.102292_bib58","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.4161\/cbt.29185","article-title":"A Salmonella Typhimurium mutant strain capable of RNAi delivery: Higher tumor-targeting and lower toxicity","volume":"15","author":"Cheng","year":"2014","journal-title":"Cancer Biol. Ther."},{"issue":"4","key":"10.1016\/j.toxrep.2026.102292_bib59","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1128\/IAI.68.4.2135-2141.2000","article-title":"Pilot study of phoP\/phoQ-deleted Salmonella enterica serovar typhimurium expressing Helicobacter priori urease in adult volunteers","volume":"68","author":"Angelakopoulos","year":"2000","journal-title":"Infect. Immun."},{"issue":"17","key":"10.1016\/j.toxrep.2026.102292_bib60","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1038\/onc.2011.395","article-title":"Development of a Listeria monocytogenes-based vaccine against hepatocellular carcinoma","volume":"31","author":"Chen","year":"2012","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.toxrep.2026.102292_bib61","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.7150\/ijms.6960","article-title":"Salmonella typhimurium mediated delivery of apoptin in human laryngeal cancer","volume":"10","author":"Guan","year":"2013","journal-title":"Int. J. Med. Sci."},{"issue":"6","key":"10.1016\/j.toxrep.2026.102292_bib62","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1083\/jcb.200201081","article-title":"The Listeria monocytogenes hemolysin has an acidic pH optimum to compartmentalize activity and prevent damage to infected host cells","volume":"156","author":"Glomski","year":"2002","journal-title":"J. Cell. Biol."},{"issue":"5493","key":"10.1016\/j.toxrep.2026.102292_bib63","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1126\/science.290.5493.992","article-title":"A PEST-like sequence in listeriolysin O essential for Listeria monocytogenes pathogenicity","volume":"290","author":"Dacatur","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.toxrep.2026.102292_bib64","first-page":"7","article-title":"Engineering bacteria for enhanced tumor therapy: from surface modification to synthetic genetic circuits","volume":"19","author":"Wang","year":"2026"},{"issue":"6","key":"10.1016\/j.toxrep.2026.102292_bib65","doi-asserted-by":"crossref","first-page":"107393","DOI":"10.1016\/j.biotechadv.2019.04.015","article-title":"Synthetic genetic circuits for programmable biological functionalities","volume":"37","author":"Xia","year":"2019","journal-title":"Biotechnol. Adv."},{"issue":"1","key":"10.1016\/j.toxrep.2026.102292_bib66","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/s41467-022-28163-5","article-title":"Genetically stable CRISPR-based kill switches for engineered microbes","volume":"13","author":"Rottinghaus","year":"2022","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.toxrep.2026.102292_bib67","doi-asserted-by":"crossref","first-page":"6116","DOI":"10.1038\/s41467-021-26367-9","article-title":"Intracellular delivery of protein drugs with an autonomously lysing bacterial system reduces tumor growth and metastases","volume":"12","author":"Raman","year":"2021","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.toxrep.2026.102292_bib68","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1007\/s10529-020-02851-y","article-title":"Design and evaluation of biological gate circuits and their therapeutic applications in a model of multidrug resistant cancers","volume":"42","author":"Soheili","year":"2020","journal-title":"Biotechnol. Lett."},{"issue":"41","key":"10.1016\/j.toxrep.2026.102292_bib69","doi-asserted-by":"crossref","first-page":"46351","DOI":"10.1021\/acsami.2c14633","article-title":"Upconversion Optogenetic Engineered Bacteria System for Time-Resolved Imaging Diagnosis and Light-Controlled Cancer Therapy","volume":"14","author":"Zhang","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.toxrep.2026.102292_bib70","article-title":"A general logic-gating framework for CAR-T and nanocarrier cancer therapies","volume":"391","author":"Rehorst","year":"2025","journal-title":"J. Control. Release"},{"issue":"9","key":"10.1016\/j.toxrep.2026.102292_bib71","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1111\/cas.12739","article-title":"p53 activated by AND gate genetic circuit under radiation and hypoxia for targeted cancer gene therapy","volume":"106","author":"Ding","year":"2015","journal-title":"Cancer Sci."},{"issue":"26","key":"10.1016\/j.toxrep.2026.102292_bib72","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1056\/NEJM198612253152606","article-title":"Tumors: Wounds That Do Not Heal","volume":"315","author":"Flier","year":"1986","journal-title":"New. Engl. J. Med."},{"key":"10.1016\/j.toxrep.2026.102292_bib73","article-title":"Microorganisms in the Treatment of Cancer: Advantages and Limitations","volume":"2018","author":"\u0141ukasiewicz","year":"2018"},{"key":"10.1016\/j.toxrep.2026.102292_bib74","first-page":"63","article-title":"Advancing clostridia to clinical trial: Past lessons and recent progress","volume":"8","author":"Mowday","year":"2016"},{"key":"10.1016\/j.toxrep.2026.102292_bib75","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1229747","article-title":"Generating Shigella that internalize into glioblastoma cells","volume":"13","author":"Shipley","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.toxrep.2026.102292_bib76","first-page":"190","article-title":"Clostridium spores as anti-tumour agents","volume":"14","author":"Van Mellaert","year":"2006"},{"issue":"19","key":"10.1016\/j.toxrep.2026.102292_bib77","doi-asserted-by":"crossref","first-page":"4442","DOI":"10.7150\/jca.35648","article-title":"Oncolytic bacteria and their potential role in bacterium-mediated tumour therapy: A conceptual analysis","volume":"10","author":"Brouchkov","year":"2019","journal-title":"J. Cancer"},{"issue":"5","key":"10.1016\/j.toxrep.2026.102292_bib78","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1111\/1751-7915.13894","article-title":"Engineering a probiotic strain of Escherichia coli to induce the regression of colorectal cancer through production of 5-aminolevulinic acid","volume":"14","author":"Chen","year":"2021","journal-title":"Microb. Biotechnol."},{"key":"10.1016\/j.toxrep.2026.102292_bib79","series-title":"ACS synthetic biology","first-page":"344","article-title":"coli TX-TL toolbox 2.0: a platform for cell-free synthetic biology","volume":"5","author":"Garamella","year":"2016"},{"issue":"11","key":"10.1016\/j.toxrep.2026.102292_bib80","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1038\/mt.2013.183","article-title":"Engineering of bacteria for the visualization of targeted delivery of a cytolytic anticancer agent","volume":"21","author":"Jiang","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.toxrep.2026.102292_bib81","first-page":"447","article-title":"Tweak to Treat: Reprograming Bacteria for Cancer Treatment","volume":"7","author":"Sieow","year":"2021"},{"key":"10.1016\/j.toxrep.2026.102292_bib82","doi-asserted-by":"crossref","first-page":"120809","DOI":"10.1016\/j.biomaterials.2021.120809","article-title":"Genetically modified bacteria for targeted phototherapy of tumor","volume":"272","author":"Deng","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.toxrep.2026.102292_bib83","article-title":"Strains, mechanism, and perspective: Salmonella -based cancer therapy","volume":"2016","author":"Wang","year":"2016"},{"issue":"1","key":"10.1016\/j.toxrep.2026.102292_bib84","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/5205","article-title":"Lipid a mutant Salmonella with suppressed virulence and TNF\u03b1 induction retain tumor-targeting in vivo","volume":"17","author":"Low","year":"1999","journal-title":"Nat. Biotechnol."},{"issue":"6","key":"10.1016\/j.toxrep.2026.102292_bib85","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1086\/315497","article-title":"Biodistribution and genetic stability of the novel antitumor agent VNP20009, a genetically modified strain of Salmonella typhimurium","volume":"181","author":"Clairmont","year":"2000","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.toxrep.2026.102292_bib86","first-page":"39","article-title":"Hypoxia-targeting bacteria in cancer therapy","volume":"100","author":"Staedtke","year":"2024"},{"issue":"2","key":"10.1016\/j.toxrep.2026.102292_bib87","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s40291-024-00695-0","article-title":"Clostridium Bacteria: Harnessing Tumour Necrosis for Targeted Gene Delivery","volume":"28","author":"Theys","year":"2024","journal-title":"Mol. Diagn. Ther."},{"issue":"5","key":"10.1016\/j.toxrep.2026.102292_bib88","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1139\/w04-019","article-title":"Cytotoxic effects of pyocin S2 produced by Pseudomonas aeruginosa on the growth of three human cell lines","volume":"50","author":"Abdi-Ali","year":"2004","journal-title":"Can. J. Microbiol."},{"issue":"12","key":"10.1016\/j.toxrep.2026.102292_bib89","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1084\/jem.20050915","article-title":"Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death","volume":"202","author":"Casares","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.toxrep.2026.102292_bib90","first-page":"925","article-title":"Bifidobacteria and their role as members of the human gut microbiota","volume":"7","author":"O\u2019Callaghan","year":"2016"},{"issue":"5","key":"10.1016\/j.toxrep.2026.102292_bib91","first-page":"741","article-title":"Mage-b vaccine delivered by recombinant Listeria monocytogenes is highly effective against breast cancer metastases","volume":"99","author":"Kim","year":"2008","journal-title":"Br. J. Cancer 2008"},{"key":"10.1016\/j.toxrep.2026.102292_bib92","first-page":"245","article-title":"Editorial: Adverse effects of cancer chemotherapy: Anything new to improve tolerance and reduce sequelae?","volume":"9","author":"Nurgali","year":"2018"},{"key":"10.1016\/j.toxrep.2026.102292_bib93","article-title":"Oncolytic bacteria: Past, present and future","volume":"366","author":"Rius-Rocabert","year":"2019"},{"issue":"20","key":"10.1016\/j.toxrep.2026.102292_bib94","article-title":"Discovery of Intratumoral Oncolytic Bacteria Toward Targeted Anticancer Theranostics","volume":"10","author":"Goto","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.toxrep.2026.102292_bib95","article-title":"Oncolytic bacteria: A revolutionary approach to cancer therapy","volume":"20","author":"Khormi","year":"2025"},{"issue":"77","key":"10.1016\/j.toxrep.2026.102292_bib96","first-page":"50540","article-title":"Measuring growth and gene expression dynamics of tumor-targeted S. typhimurium bacteria","author":"Danino","year":"2013","journal-title":"J. Vis. Exp. JoVE"},{"issue":"11","key":"10.1016\/j.toxrep.2026.102292_bib97","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/nrc2934","article-title":"Engineering the perfect (bacterial) cancer therapy","volume":"10","author":"Forbes","year":"2010","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.toxrep.2026.102292_bib98","first-page":"44","article-title":"Advances in Immunotherapy for Cancer Treatment: Targeting the Immune System to Fight Tumors","volume":"11","author":"Kulkarni","year":"2024","journal-title":"Univers. Res. Rep."},{"key":"10.1016\/j.toxrep.2026.102292_bib99","article-title":"Impact of Immune Cells in the Tumor Microenvironment of Prostate Cancer Metastasis","volume":"13","author":"Messex","year":"2023"},{"key":"10.1016\/j.toxrep.2026.102292_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2020.105651","article-title":"Breast cancer targeted\/ therapeutic with double and triple fusion Immunotoxins","volume":"200","author":"Goleij","year":"2020","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.toxrep.2026.102292_bib101","doi-asserted-by":"crossref","first-page":"7396","DOI":"10.1038\/ncomms8396","article-title":"Site-specific processing of Ras and Rap1 Switch i by a MARTX toxin effector domain","volume":"6","author":"Antic","year":"2015","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.toxrep.2026.102292_bib102","doi-asserted-by":"crossref","first-page":"38","DOI":"10.51847\/Ovv3nzS2Wn","article-title":"Immunotoxins and Their Role in Prostate Cancer Treatment","volume":"12","author":"Buzlea","year":"2024","journal-title":"Clin. Cancer Investig. J."},{"issue":"3","key":"10.1016\/j.toxrep.2026.102292_bib103","doi-asserted-by":"crossref","DOI":"10.1038\/s41408-018-0066-7","article-title":"The CD20-specific engineered toxin antibody MT-3724 exhibits lethal effects against mantle cell lymphoma","volume":"8","author":"Huang","year":"2018","journal-title":"Blood Cancer J."},{"issue":"2","key":"10.1016\/j.toxrep.2026.102292_bib104","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ejpb.2010.03.003","article-title":"Claudin-4-targeting of diphtheria toxin fragment A using a C-terminal fragment of Clostridium perfringens enterotoxin","volume":"75","author":"Kakutani","year":"2010","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.toxrep.2026.102292_bib105","series-title":"Microbial Toxins in Food Systems: Causes, Mechanisms, Complications, and Metabolism","first-page":"471","article-title":"Bacterial Toxins in the Management of Colon Cancer: Current Perspective","author":"Shoaib","year":"2024"},{"key":"10.1016\/j.toxrep.2026.102292_bib106","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.624618","article-title":"Methods and Techniques to Facilitate the Development of Clostridium novyi NT as an Effective, Therapeutic Oncolytic Bacteria","volume":"12","author":"Dailey","year":"2021","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.toxrep.2026.102292_bib107","doi-asserted-by":"crossref","DOI":"10.1177\/17588359241309461","article-title":"Innovative payloads for ADCs in cancer treatment: moving beyond the selective delivery of chemotherapy","volume":"17","author":"Izzo","year":"2025","journal-title":"Ther. Adv. Med. Oncol."},{"issue":"8","key":"10.1016\/j.toxrep.2026.102292_bib108","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/s41573-023-00709-2","article-title":"Antibody\u2013drug conjugates come of age in oncology","volume":"22","author":"Dumontet","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"issue":"8","key":"10.1016\/j.toxrep.2026.102292_bib109","doi-asserted-by":"crossref","first-page":"e671","DOI":"10.1002\/mco2.671","article-title":"Antibody\u2013drug conjugates in cancer therapy: mechanisms and clinical studies","volume":"5","author":"He","year":"2024","journal-title":"MedComm"},{"key":"10.1016\/j.toxrep.2026.102292_bib110","series-title":"Innovations for next-generation antibody-drug conjugates","year":"2018"},{"issue":"2","key":"10.1016\/j.toxrep.2026.102292_bib111","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1158\/1535-7163.MCT-21-0580","article-title":"Cellular-resolution imaging of bystander payload tissue penetration from antibody-drug conjugates","volume":"21","author":"Khera","year":"2022","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.toxrep.2026.102292_bib112","article-title":"Bystander effect in antibody-drug conjugates: Navigating the fine line in tumor heterogeneity","volume":"216","author":"Wang","year":"2025"},{"key":"10.1016\/j.toxrep.2026.102292_bib113","first-page":"120","article-title":"Bacterial-directed enzyme prodrug therapy","volume":"170","author":"Lehouritis","year":"2013"},{"key":"10.1016\/j.toxrep.2026.102292_bib114","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.addr.2017.06.013","article-title":"Prodrugs in medicinal chemistry and enzyme prodrug therapies","volume":"118","author":"Walther","year":"2017","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.toxrep.2026.102292_bib115","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.mehy.2017.01.018","article-title":"pursuit of cancer metastasis therapy by bacteria and its biofilms: History or future","volume":"100","author":"Adnan","year":"2017","journal-title":"Med. Hypotheses"},{"issue":"3","key":"10.1016\/j.toxrep.2026.102292_bib116","first-page":"5","article-title":"Dual assessment of cytotoxicity induced by Lactobacillus acidophilus cellfree supernatants, Ggold nanoparticles, and their combination in MDA-MB-231 and rat embryonic fibroblast cell lines","volume":"12","author":"Hadid","year":"2025","journal-title":"Opera Med. Et. Physiol."},{"key":"10.1016\/j.toxrep.2026.102292_bib117","series-title":"Advancements in Biosurfactants Research","first-page":"439","article-title":"Biosurfactants as Potential Antitumor Agents","author":"Ukaegbu","year":"2023"},{"key":"10.1016\/j.toxrep.2026.102292_bib118","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jconrel.2017.12.013","article-title":"Bacillus spore-based oral carriers loading curcumin for the therapy of colon cancer","volume":"271","author":"Yin","year":"2018","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.toxrep.2026.102292_bib119","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1200\/JCO.2002.20.1.142","article-title":"Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma","volume":"20","author":"Toso","year":"2002","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.toxrep.2026.102292_bib120","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.molcel.2017.10.033","article-title":"Rational design of evolutionarily stable microbial kill switches","volume":"68","author":"Stirling","year":"2017","journal-title":"Molecular cell"},{"key":"10.1016\/j.toxrep.2026.102292_bib121","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.actbio.2022.05.016","article-title":"Nanodrug-loaded Bifidobacterium bifidum conjugated with anti-death receptor antibody for tumor-targeted photodynamic and sonodynamic synergistic therapy","volume":"146","author":"Li","year":"2022","journal-title":"Acta Biomater."},{"issue":"7","key":"10.1016\/j.toxrep.2026.102292_bib122","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201846153","article-title":"A critical juncture for synthetic biology: Lessons from nanotechnology could inform public discourse and further development of synthetic biology","volume":"19","author":"Trump","year":"2018","journal-title":"The EMBO Reports"},{"issue":"2","key":"10.1016\/j.toxrep.2026.102292_bib123","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.tibtech.2014.10.008","article-title":"The limits of synthetic biology","volume":"33","author":"Zakeri","year":"2015","journal-title":"Trends Biotechnol."},{"issue":"1","key":"10.1016\/j.toxrep.2026.102292_bib124","doi-asserted-by":"crossref","first-page":"MSB4100202","DOI":"10.1038\/msb4100202","article-title":"Synthetic biology: promises and challenges","volume":"3","author":"Serrano","year":"2007","journal-title":"Mol. Syst. Biol."},{"issue":"1","key":"10.1016\/j.toxrep.2026.102292_bib125","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jobb.2018.12.003","article-title":"Synthetic biology: recent progress, biosafety and biosecurity concerns, and possible solutions","volume":"1","author":"Wang","year":"2019","journal-title":"J. Biosaf. Biosecurity"},{"issue":"8","key":"10.1016\/j.toxrep.2026.102292_bib126","doi-asserted-by":"crossref","first-page":"6207","DOI":"10.1007\/s11033-020-05565-6","article-title":"Synthetic biology in various cellular and molecular fields: applications, limitations, and perspective","volume":"47","author":"Safaei","year":"2020","journal-title":"Mol. Biol. Rep."},{"issue":"7","key":"10.1016\/j.toxrep.2026.102292_bib127","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/s41591-019-0498-z","article-title":"Programmable bacteria induce durable tumor regression and systemic antitumor immunity","volume":"25","author":"Chowdhury","year":"2019","journal-title":"Nat. Med."},{"issue":"42","key":"10.1016\/j.toxrep.2026.102292_bib128","doi-asserted-by":"crossref","first-page":"e07820","DOI":"10.1002\/advs.202507820","article-title":"Engineering bacteria as living therapeutics in cancer therapy","volume":"12","author":"Chen","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.toxrep.2026.102292_bib129","first-page":"465","article-title":"Anti-Cancer Strategies Using Anaerobic Spore-Forming Bacteria Clostridium: Advances and Synergistic Approaches","volume":"15","author":"Singh","year":"2025"},{"issue":"4","key":"10.1016\/j.toxrep.2026.102292_bib130","doi-asserted-by":"crossref","first-page":"247","DOI":"10.4161\/bioe.21004","article-title":"ClosTron-mediated engineering of Clostridium","volume":"3","author":"Kuehne","year":"2012","journal-title":"Bioengineered"},{"issue":"7735","key":"10.1016\/j.toxrep.2026.102292_bib131","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/s41586-018-0774-y","article-title":"Disruption of a self-amplifying catecholamine loop reduces cytokine release syndrome","volume":"564","author":"Staedtke","year":"2018","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.toxrep.2026.102292_bib132","article-title":"Enhancing tumor-specific recognition of programmable synthetic bacterial consortium for precision therapy of colorectal cancer","volume":"10","author":"Zhou","year":"2024","journal-title":"Npj Biofilms Micro"},{"issue":"31","key":"10.1016\/j.toxrep.2026.102292_bib133","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202406486","article-title":"Self-Adjusting Engineered Probiotic for Targeted Tumor Colonization and Local Therapeutics Delivery","volume":"12","author":"Zou","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.toxrep.2026.102292_bib134","first-page":"385","article-title":"Clostridia as live biotherapeutics: can modified Clostridium species enhance disease treatments?","volume":"18","author":"Kubiak","year":"2023"},{"issue":"1","key":"10.1016\/j.toxrep.2026.102292_bib135","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1038\/s41467-022-29065-2","article-title":"Ultrasound-controllable engineered bacteria for cancer immunotherapy","volume":"13","author":"Abedi","year":"2022","journal-title":"Nat. Commun."},{"issue":"530","key":"10.1016\/j.toxrep.2026.102292_bib136","doi-asserted-by":"crossref","first-page":"eaax0876","DOI":"10.1126\/scitranslmed.aax0876","article-title":"Engineered probiotics for local tumor delivery of checkpoint blockade nanobodies","volume":"12","author":"Gurbatri","year":"2020","journal-title":"Sci. Transl. Med."},{"issue":"39","key":"10.1016\/j.toxrep.2026.102292_bib137","doi-asserted-by":"crossref","first-page":"26858","DOI":"10.1021\/acsnano.4c08117","article-title":"Spatiotemporal delivery of dual nanobodies by engineered probiotics to reverse tumor immunosuppression via targeting tumor-derived exosomes","volume":"18","author":"Qin","year":"2024","journal-title":"ACS nano"},{"issue":"9","key":"10.1016\/j.toxrep.2026.102292_bib138","doi-asserted-by":"crossref","first-page":"2414233","DOI":"10.1002\/advs.202414233","article-title":"On\u2010Demand controlled release multi\u2010drugs delivery system for spatiotemporally synergizing antitumor immunotherapy","volume":"12","author":"Liang","year":"2025","journal-title":"Adv. Sci."},{"issue":"1","key":"10.1016\/j.toxrep.2026.102292_bib139","doi-asserted-by":"crossref","first-page":"2106669","DOI":"10.1002\/adma.202106669","article-title":"Spatiotemporally controllable distribution of combination therapeutics in solid tumors by dually modified bacteria","volume":"34","author":"Wang","year":"2022","journal-title":"Adv. Mater."},{"issue":"15","key":"10.1016\/j.toxrep.2026.102292_bib140","doi-asserted-by":"crossref","first-page":"5945","DOI":"10.7150\/thno.98257","article-title":"Enhancing photothermal therapy of tumors with image-guided thermal control of gene-expressing bacteria","volume":"14","author":"Zeng","year":"2024","journal-title":"Theranostics"},{"issue":"5","key":"10.1016\/j.toxrep.2026.102292_bib141","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.3390\/cancers15051486","article-title":"Constitutive expression of a cytotoxic anticancer protein in tumor-colonizing bacteria","volume":"15","author":"Mai","year":"2023","journal-title":"Cancers"},{"issue":"36","key":"10.1016\/j.toxrep.2026.102292_bib142","doi-asserted-by":"crossref","first-page":"2404069","DOI":"10.1002\/advs.202404069","article-title":"Programmable bacteria with dynamic virulence modulation system for precision antitumor immunity","volume":"11","author":"Wu","year":"2024","journal-title":"Adv. Sci."},{"issue":"6","key":"10.1016\/j.toxrep.2026.102292_bib143","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0180034","article-title":"Intratumoural production of TNF\u03b1 by bacteria mediates cancer therapy","volume":"12","author":"Murphy","year":"2017","journal-title":"PloS one"},{"issue":"8","key":"10.1016\/j.toxrep.2026.102292_bib144","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202309332","article-title":"Nanozyme-Coated Bacteria Hitchhike on CD11b+ Immune Cells to Boost Tumor Radioimmunotherapy","volume":"36","author":"Li","year":"2024","journal-title":"Adv. Mater."},{"issue":"5","key":"10.1016\/j.toxrep.2026.102292_bib145","doi-asserted-by":"crossref","first-page":"nwad031","DOI":"10.1093\/nsr\/nwad031","article-title":"Programming the lifestyles of engineered bacteria for cancer therapy","volume":"10","author":"Fu","year":"2023","journal-title":"Natl. Sci. Rev."},{"issue":"10","key":"10.1016\/j.toxrep.2026.102292_bib146","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1021\/acschembio.4c00250","article-title":"Enhancing the Anticancer Activity of Attenuated Listeria monocytogenes by Cell Wall Functionalization with \u201cClickable\u201d Doxorubicin","volume":"19","author":"Lepori","year":"2024","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.toxrep.2026.102292_bib147","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.actbio.2022.11.037","article-title":"Live bio-nano-sonosensitizer targets malignant tumors in synergistic therapy","volume":"155","author":"Yin","year":"2023","journal-title":"Acta Biomater."},{"key":"10.1016\/j.toxrep.2026.102292_bib148","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.mattod.2025.03.018","article-title":"Engineered radiation-sensitive probiotic for synergistic tumor cell cycle blockade and immunomodulation to potentiate radio-immunotherapy in pancreatic cancer","volume":"86","author":"Yao","year":"2025","journal-title":"Mater. Today"},{"issue":"1","key":"10.1016\/j.toxrep.2026.102292_bib149","doi-asserted-by":"crossref","first-page":"7466","DOI":"10.1038\/s41467-022-35130-7","article-title":"Engineered Lactococcus lactis secreting Flt3L and OX40 ligand for in situ vaccination-based cancer immunotherapy","volume":"13","author":"Zhu","year":"2022","journal-title":"Nat. Commun."}],"container-title":["Toxicology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214750026000946?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214750026000946?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T09:53:57Z","timestamp":1790330037000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214750026000946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":149,"alternative-id":["S2214750026000946"],"URL":"https:\/\/doi.org\/10.1016\/j.toxrep.2026.102292","relation":{},"ISSN":["2214-7500"],"issn-type":[{"value":"2214-7500","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthetic biology of oncolytic bacteria: Comparative microbial chassis and precise killing strategies","name":"articletitle","label":"Article Title"},{"value":"Toxicology Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxrep.2026.102292","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102292"}}